These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10799789)

  • 21. Cross-reactivity of existing equine influenza vaccines with a new strain of equine influenza virus from China.
    Chambers TM
    Vet Rec; 1992 Oct; 131(17):388-91. PubMed ID: 1333665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic differences between equine influenza virus vaccine strains and Florida sublineage clade 1 strains isolated in Europe in 2019.
    Nemoto M; Ohta M; Yamanaka T; Kambayashi Y; Bannai H; Tsujimura K; Yamayoshi S; Kawaoka Y; Cullinane A
    Vet J; 2021 Jun; 272():105674. PubMed ID: 33941332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza.
    Tabynov K; Kydyrbayev Zh; Ryskeldinova Sh; Assanzhanova N; Sansyzbay A
    Vaccine; 2014 May; 32(25):2965-71. PubMed ID: 24726250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses.
    Ozaki H; Sugiura T; Sugita S; Imagawa H; Kida H
    Vet Microbiol; 2001 Sep; 82(2):111-9. PubMed ID: 11423202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and subunit vaccines based on the stem domain of the equine influenza hemagglutinin provide homosubtypic protection against heterologous strains.
    Ibañez LI; Caldevilla CA; Paredes Rojas Y; Mattion N
    Vaccine; 2018 Mar; 36(12):1592-1598. PubMed ID: 29454522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy.
    Daly JM; Elton D
    Vaccine; 2013 Dec; 31(51):6043-5. PubMed ID: 23831320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Field observations on influenza vaccination among horses in Britain, 1971-1976.
    Powell DG; Burrows R; Spooner P; Mumford J; Thomson G
    Dev Biol Stand; 1977 Jun 1-3; 39():347-52. PubMed ID: 604119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
    Morley PS; Townsend HG; Bogdan JR; Haines DM
    J Am Vet Med Assoc; 1999 Jul; 215(1):61-6. PubMed ID: 10397067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
    Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
    Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for the use of influenza vaccines in horses and the importance of antigenic drift.
    Baker DJ
    Equine Vet J; 1986 Mar; 18(2):93-6. PubMed ID: 3698963
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.
    Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Kondo T; Matsumura T; Gildea S; Cullinane A
    Influenza Other Respir Viruses; 2016 Nov; 10(6):536-539. PubMed ID: 27465864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equine influenza.
    Wilson WD
    Vet Clin North Am Equine Pract; 1993 Aug; 9(2):257-82. PubMed ID: 8358645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom.
    Edlund Toulemonde C; Daly J; Sindle T; Guigal PM; Audonnet JC; Minke JM
    Vet Rec; 2005 Mar; 156(12):367-71. PubMed ID: 15816180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equine influenza vaccine performance: still learning lessons from the field.
    Newton JR
    Vet J; 2001 Mar; 161(2):107-9. PubMed ID: 11243681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.